Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated just now
Peer-reviewedCC BYFrontiers in pharmacology

Hepatoprotective Formula 919 ameliorates hepatic steatosis and metabolic disturbance in NAFLD with involvement of AMPK signaling

  • Manman Chen1
  • Zheng Xu2
  • Yu Chen1
  • Yuemei Xu1
  • Lan Zhang1
  • Yiling Zhao1
  • Pengfei Gao3
  1. 1Department of Traditional Chinese Medicine, Jinshan Hospital, Fudan University , ,
  2. 2Future Network Center, Purple Mountain Laboratories , ,
  3. 3Department of Traditional Chinese Medicine, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University , ,
Read full textPDFCite

Related

  1. Therapeutic targeting of the PRMT6/FOXK1 axis restores lipid homeostasis and ameliorates hepatic steatosis and steatohepatitis in mice.
    Yang Sun, Tao Chen, Lei Zhang +5
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  2. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
    Marina Serrano-Maciá, Jorge Simón, Maria González-Rellan +28
    Molecular metabolismPeer-reviewedCC BY-NC-ND50 citedEpidemiology & public healthHAL
  3. Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling
    Chenglang Jiang, Weiqi Shen, Xin Liu +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefDOAJ
  4. The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study
    P. Deb, D. Bagar, P. Kumar +10
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv

Cite

BibTeXRIS
BibTeX
@article{chen2026hepatoprotective,
  title = {{Hepatoprotective Formula 919 ameliorates hepatic steatosis and metabolic disturbance in NAFLD with involvement of AMPK signaling}},
  author = {Manman Chen and Zheng Xu and Yu Chen and Yuemei Xu and Lan Zhang and Yiling Zhao and Pengfei Gao},
  journal = {Frontiers in pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13654718},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Hepatoprotective Formula 919 ameliorates hepatic steatosis and metabolic disturbance in NAFLD with involvement of AMPK signaling
AU  - Manman Chen
AU  - Zheng Xu
AU  - Yu Chen
AU  - Yuemei Xu
AU  - Lan Zhang
AU  - Yiling Zhao
AU  - Pengfei Gao
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in pharmacology
UR  - https://europepmc.org/article/PMC/PMC13654718
SN  - 1663-9812
ER  -